{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-06",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "65862-290",
      "generic_name": "Ribavirin",
      "labeler_name": "Aurobindo Pharma Limited",
      "brand_name": "Ribavirin",
      "active_ingredients": [
        {
          "name": "RIBAVIRIN",
          "strength": "200 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "65862-290-05",
          "description": "500 CAPSULE in 1 BOTTLE (65862-290-05)",
          "marketing_start_date": "20090917",
          "sample": false
        },
        {
          "package_ndc": "65862-290-18",
          "description": "180 CAPSULE in 1 BOTTLE (65862-290-18)",
          "marketing_start_date": "20090917",
          "sample": false
        },
        {
          "package_ndc": "65862-290-42",
          "description": "42 CAPSULE in 1 BOTTLE (65862-290-42)",
          "marketing_start_date": "20090917",
          "sample": false
        },
        {
          "package_ndc": "65862-290-56",
          "description": "56 CAPSULE in 1 BOTTLE (65862-290-56)",
          "marketing_start_date": "20090917",
          "sample": false
        },
        {
          "package_ndc": "65862-290-70",
          "description": "70 CAPSULE in 1 BOTTLE (65862-290-70)",
          "marketing_start_date": "20090917",
          "sample": false
        },
        {
          "package_ndc": "65862-290-84",
          "description": "84 CAPSULE in 1 BOTTLE (65862-290-84)",
          "marketing_start_date": "20090917",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Aurobindo Pharma Limited"
        ],
        "rxcui": [
          "312817"
        ],
        "spl_set_id": [
          "35f99f76-f2ef-4a81-91ff-285419664be3"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175459",
          "N0000175466"
        ],
        "pharm_class_epc": [
          "Nucleoside Analog Antiviral [EPC]"
        ],
        "unii": [
          "49717AWG6K"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "CAPSULE",
      "spl_id": "229cfa05-05e1-493e-87ba-0511fed12e66",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20090917",
      "product_id": "65862-290_229cfa05-05e1-493e-87ba-0511fed12e66",
      "application_number": "ANDA079117",
      "brand_name_base": "Ribavirin",
      "pharm_class": [
        "Nucleoside Analog Antiviral [EPC]",
        "Nucleoside Analog [EXT]"
      ]
    }
  ]
}